NeuroSigma Announces New Telehealth Option for Patients and Caregivers Interested in eTNS for Pediatric ADHD
March 01, 2023 11:00 ET | NeuroSigma, Inc.
LOS ANGELES, March 01, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced a new option for patients and caregivers seeking a telehealth evaluation for the Monarch eTNS System®. NeuroSigma is a Los...
NeuroSigma Announces Strategic Digital Marketing Partnership with Data360
January 31, 2023 09:00 ET | NeuroSigma, Inc.
LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) technology for treating...
NeuroSigma Announces that Enrollment Commences in Two Large, Double-Blind Trials of eTNS for Pediatric ADHD
November 08, 2022 10:00 ET | NeuroSigma, Inc.
Trials recruiting subjects at UCLA and Seattle Children’s Hospital in the United States, and at King’s College London and the University of Southampton in the United Kingdom Trials sponsored by the...
NeuroSigma Announces Commercial Launch of The Monarch eTNS® System for the Treatment of Pediatric ADHD at Annual Meeting of the American Academy of Child and Adolescent Psychiatry
October 17, 2022 09:00 ET | NeuroSigma, Inc.
LOS ANGELES, Oct. 17, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, today announced the commercial launch of The Monarch eTNS System at the annual meeting of...
Founding Executive Director, ODU Research Center for Bioelectronics
Gymama Slaughter Appointed Founding Executive Director at ODU’s Center for Bioelectronics
December 06, 2021 11:16 ET | Old Dominion University
Norfolk, VA, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Gymama Slaughter has been appointed as the founding executive director of Old Dominion University's Research Center for Bioelectronics. She will lead...
US Nuclear Secures Its Position at Bioelectronics Startup Grapheton
October 19, 2020 08:30 ET | US Nuclear Corp.
LOS ANGELES, CA, Oct. 19, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – In addition to US Nuclear’s (OTC: UCLE) 40% stake in Grapheton, CEO Robert Goldstein has recently taken a seat on Grapheton’s...
Endonovo Therapeutics Developing Non-Invasive Bioelectronic Therapy for Urinary Incontinence
August 14, 2014 09:00 ET | Endonovo Therapeutics, Inc.
LOS ANGELES, CA--(Marketwired - Aug 14, 2014) - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a developer of non-invasive bioelectronic therapies, announced today that it...
Clear Channel Business Talk Radio's 'The Traders Network' Interview With Andrew J. Whelan, CEO of BioElectronics Corp Now Available for Online Streaming DALLAS, TX--(Marketwired - Apr 15, 2014) -  The Traders Network Show Broadcasted live Daily on Clear Channel Business Talk Radio announced today that Andrew Whelan CEO of BioElectronics...
Point-of-Care Technologies Will Transform Customer Markets in the Next Decade
March 06, 2014 07:30 ET | Lux Research
BOSTON, MA--(Marketwired - Mar 6, 2014) - Fueled by point-of-care (POC) technologies, the health care industry is headed for transformative change toward a patient-centric model. The near-term...
New Technologies, Business Models Emerging to Fix Trillion-Dollar Health Care Market
August 13, 2013 07:39 ET | Lux Research
BOSTON, MA--(Marketwired - Aug 13, 2013) - Soaring health care costs across the globe, accompanied by growing demands from aging populations and emerging economies, are fueling technological and...